SIR ePoster Library

Managing tunneled/implanted central venous access devices in patients with bacteremia: acomparative analysis across two institutions
SIR ePoster library. Dombrowski J. 03/04/17; 169990; 554
James Dombrowski
James Dombrowski
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)

Final ID
554

Type
Original Scientific Research-Oral or Pos

Authors
J Dombrowski1, R Ogilvie1, B Glaenzer1, C Molvar1, T Ozga2, M Borge1, A Malamis1, P Amin1

Institutions
1Loyola University Medical Center, Maywood, IL, 2Gottlieb Memorial Hospital, Melrose Park, IL

Purpose
To compare the efficacy of exchange versus removal of implanted/tunneled central venous access devices in patients with bacteremia, evaluating for microorganism recurrence.

Materials & Methods
Retrospective search from 7/2015 to 7/2016 yielded 82 patients with bacteremia referred to IR for management of implanted/tunneled central venous access devices. 44 patients underwent removal and 38 patients underwent exchange. Recurrence rates after bacteremia clearance through 30 days were obtained. Blood cultures from device were considered 'matched' if peripheral blood cultures grew same organism. Negative catheter tip culture rates were obtained.

Results
See chart.

Conclusions
Hospitalized patients with bacteremia undergoing exchange of tunneled/implanted central venous access devices did not experience prolonged leukocytosis compared to those undergoing removal. Device exchange did not lead to significantly increased rates of bacteremia recurrence at 30 days when compared to removal. Negative catheter tip culture rates are high for both cohorts. Work is ongoing to evaluate species of microorganisms cultured and its impact on organism clearance.

Final ID
554

Type
Original Scientific Research-Oral or Pos

Authors
J Dombrowski1, R Ogilvie1, B Glaenzer1, C Molvar1, T Ozga2, M Borge1, A Malamis1, P Amin1

Institutions
1Loyola University Medical Center, Maywood, IL, 2Gottlieb Memorial Hospital, Melrose Park, IL

Purpose
To compare the efficacy of exchange versus removal of implanted/tunneled central venous access devices in patients with bacteremia, evaluating for microorganism recurrence.

Materials & Methods
Retrospective search from 7/2015 to 7/2016 yielded 82 patients with bacteremia referred to IR for management of implanted/tunneled central venous access devices. 44 patients underwent removal and 38 patients underwent exchange. Recurrence rates after bacteremia clearance through 30 days were obtained. Blood cultures from device were considered 'matched' if peripheral blood cultures grew same organism. Negative catheter tip culture rates were obtained.

Results
See chart.

Conclusions
Hospitalized patients with bacteremia undergoing exchange of tunneled/implanted central venous access devices did not experience prolonged leukocytosis compared to those undergoing removal. Device exchange did not lead to significantly increased rates of bacteremia recurrence at 30 days when compared to removal. Negative catheter tip culture rates are high for both cohorts. Work is ongoing to evaluate species of microorganisms cultured and its impact on organism clearance.

Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies